** Shares of biotechnology firm Windtree Therapeutics WINT.O down 8.30% at about $0.49
** CEO Craig Fraser to retire, effective Dec. 1
** Fraser to remain on the board as chairman
** Jed Latkin, current director, appointed as CEO
** Including session gains, stock had fallen 96.1% YTD
(Reporting by Nithyashree R B)
((NithyashreeRB@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。